Controlled Substances - As introduced, permits a prescriber who is not a patient's obstetrical or gynecological provider to prescribe buprenorphine products to certain patients if the prescriber is a member of the same specialty practice group as the patient's obstetrical or gynecological provider. - Amends TCA Title 33; Title 53 and Title 63.
Bill status
in committee
1 of 4 stages cleared
Introduction
Feb 2019
Committee Review
Floor Vote
Governor
Introduced Feb 5, 2019
Last action Feb 19, 2020
Floor votes
How they voted
No floor votes recorded yet.
Full legislative history
Actions timeline
Total actions
12
Key actions
5
Committee
8
Feb 12, 2020
Lower · Passed
Placed on s/c cal Mental Health & Substance Abuse Subcommittee for 2/19/2020
lower
Apr 10, 2019
Committee
Assigned to General Subcommittee of Senate Health and Welfare Committee
upper
Apr 4, 2019
Upper · Passed
Placed on Senate Health and Welfare Committee calendar for 4/10/2019
upper
Apr 3, 2019
Lower · Passed
Action Def. in s/c Mental Health & Substance Abuse Subcommittee to First Calendar of 2020
lower
Mar 27, 2019
Lower · Passed
Placed on s/c cal Mental Health & Substance Abuse Subcommittee for 4/3/2019
lower
Feb 11, 2019
Committee
Assigned to s/c Mental Health & Substance Abuse Subcommittee
lower
Feb 7, 2019
Committee
P2C, ref. to Health Committee
lower
Feb 7, 2019
Upper · Passed
Passed on Second Consideration, refer to Senate Health and Welfare Committee
upper
Feb 6, 2019
Introduced
Intro., P1C.
lower
Feb 6, 2019
Introduced
Introduced, Passed on First Consideration
upper
2 primary · 0 co-sponsors
Sponsors
Ask Maddy
·
AI policy assistant
Ask Maddy about SB 767
Scope: TN
Hi! I can help you understand SB 767. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline